Geode Capital Management, LLC Nemaura Medical Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.72 - $3.13 $490 - $892	-285 Reduced 0.26%	107,897 $183,000
Q1 2022 May 13, 2022	SELL	$3.78 - $4.66 $79 - $97	-21 Reduced 0.02%	108,182 $472,000
Q4 2021 Feb 11, 2022	SELL	$4.12 - $6.35 $49 - $76	-12 Reduced 0.01%	108,203 $493,000
Q3 2021 Nov 12, 2021	BUY	$5.76 - $9.95 $135,895 - $234,750	23,593 Added 27.88%	108,215 $650,000
Q2 2021 Aug 13, 2021	SELL	$4.7 - $16.7 $234,370 - $832,762	-49,866 Reduced 37.08%	84,622 $875,000
Q1 2021 May 12, 2021	BUY	$3.79 - $9.78 $267,221 - $689,558	70,507 Added 110.2%	134,488 $1.03 Million
Q4 2020 Feb 12, 2021	BUY	$3.47 - $4.52 $15,295 - $19,924	4,408 Added 7.4%	63,981 $241,000
Q3 2020 Nov 13, 2020	BUY	$3.55 - $9.99 $59,029 - $166,113	16,628 Added 38.72%	59,573 $211,000
Q2 2020 Aug 13, 2020	BUY	$4.75 - $15.38 $203,988 - $660,494	42,945 New	42,945 $397,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.